Partners HealthCare System Inc-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Partners HealthCare System Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013383
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:46
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Partners HealthCare System Inc (PHS) is a nonprofit integrated health care organization. It operates a network of community and specialty hospitals, a physician network, managed care organizations, home health and long-term care centers, community health centers and other health care entities. The organization focuses on providing patient care, research, teaching, and other services to patients and their families in the community through its network. It offers a wide range of services primarily to patients from the Greater Boston area along with New England and beyond. PHS holds expertise in the area of biomedical research, and is a principal teaching affiliate of Harvard Medical School. The organization is formed by the joint effort of Brigham and Women’s Hospital and Massachusetts General Hospital. PHS is headquartered at Boston, Massachusetts, the US.

Partners HealthCare System Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Partners HealthCare System Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Partners HealthCare System Inc, Medical Devices Deals, 2011 to YTD 2017 9
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Deal Details 14
Asset Purchase 14
Partners HealthCare Receives Approval from State Attorney General to Acquire South Shore Hospital 14
Partners HealthCare To Acquire Two Hospitals From Hallmark Health 15
Venture Financing 16
Magenta Therapeutics Raises USD50 Million in Series B Financing 16
Syntimmune Raises USD8 Million in Final Tranche of Series A Financing Round 18
ImmuneXcite Raises USD8.6 Million in Series A-1 Financing 19
Syntimmune Raises USD10 Million in Second Tranche of Series A Financing Round 20
Spero Therapeutics to Raise USD30 Million in Series B Preferred Financing 21
Editas Medicine Raises USD120 Million in Series B Financing 22
Spero Therapeutics Raises USD30 Million in Extended Series A Financing 24
Lysosomal Therapeutics Raises USD20 Million in Series A Financing 25
Quartet Medicine Raises USD17 Million in Series A Venture Financing 26
Raze Therapeutics Raises USD24 Million in Series A Venture Financing 27
Lysosomal Therapeutics Raises US$4.8 Million In Seed Financing 29
Spero Therapeutics Raises USD3 Million in Series A Venture Financing 31
Editas Medicine Raises US$43 Million In Series A Financing 32
Annovation BioPharma Raises US$8 Million In Series A Financing 34
RaNA Therapeutics Raises Additional US$18 Million In Series A Financing 35
Partnerships 37
Jiahui International Hospital, Partners HealthCare International and Brigham and Women’s Hospital to Co-Develop Women’s Health Center 37
Partners HealthCare to Form Joint Venture with MedSpring Urgent Care 38
Acquisition 39
Novartis Acquires CoStim Pharma 39
Partners HealthCare Completes Acquisition Of Cooley Dickinson Hospital 41
Partners HealthCare System Inc – Key Competitors 42
Partners HealthCare System Inc – Key Employees 43
Partners HealthCare System Inc – Locations And Subsidiaries 44
Head Office 44
Other Locations & Subsidiaries 44
Joint Venture 44
Recent Developments 45
Government and Public Interest 45
Oct 13, 2016: NIH funds additional medical centers to expand national precision medicine research program 45
Appendix 46
Methodology 46
About GlobalData 46
Contact Us 46
Disclaimer 46

List of Tables
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Key Facts, 2015 2
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Partners HealthCare System Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Partners HealthCare System Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Partners HealthCare System Inc, Medical Devices Deals, 2011 to YTD 2017 9
Partners HealthCare System Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Partners HealthCare Receives Approval from State Attorney General to Acquire South Shore Hospital 14
Partners HealthCare To Acquire Two Hospitals From Hallmark Health 15
Magenta Therapeutics Raises USD50 Million in Series B Financing 16
Syntimmune Raises USD8 Million in Final Tranche of Series A Financing Round 18
ImmuneXcite Raises USD8.6 Million in Series A-1 Financing 19
Syntimmune Raises USD10 Million in Second Tranche of Series A Financing Round 20
Spero Therapeutics to Raise USD30 Million in Series B Preferred Financing 21
Editas Medicine Raises USD120 Million in Series B Financing 22
Spero Therapeutics Raises USD30 Million in Extended Series A Financing 24
Lysosomal Therapeutics Raises USD20 Million in Series A Financing 25
Quartet Medicine Raises USD17 Million in Series A Venture Financing 26
Raze Therapeutics Raises USD24 Million in Series A Venture Financing 27
Lysosomal Therapeutics Raises US$4.8 Million In Seed Financing 29
Spero Therapeutics Raises USD3 Million in Series A Venture Financing 31
Editas Medicine Raises US$43 Million In Series A Financing 32
Annovation BioPharma Raises US$8 Million In Series A Financing 34
RaNA Therapeutics Raises Additional US$18 Million In Series A Financing 35
Jiahui International Hospital, Partners HealthCare International and Brigham and Women's Hospital to Co-Develop Women's Health Center 37
Partners HealthCare to Form Joint Venture with MedSpring Urgent Care 38
Novartis Acquires CoStim Pharma 39
Partners HealthCare Completes Acquisition Of Cooley Dickinson Hospital 41
Partners HealthCare System Inc, Key Competitors 42
Partners HealthCare System Inc, Key Employees 43
Partners HealthCare System Inc, Subsidiaries 44
Partners HealthCare System Inc, Joint Venture 44

★海外企業調査レポート[Partners HealthCare System Inc-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Eloxx Pharmaceuticals Inc (ELOX):企業の財務・戦略的SWOT分析
    Eloxx Pharmaceuticals Inc (ELOX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • GlaxoSmithKline Plc:企業のM&A・事業提携・投資動向
    GlaxoSmithKline Plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's GlaxoSmithKline Plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • iNova Pharmaceuticals (Australia) Pty Ltd:企業の戦略的SWOT分析
    iNova Pharmaceuticals (Australia) Pty Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • LG International Corp (001120):石油・ガス:M&Aディール及び事業提携情報
    Summary LG International Corp (LGI) is a diversified enterprise with business interests in various sectors including resources, infrastructure and industrial, and logistics. The company’s resources business is involved in coal, oil and gas, metals, food and commodities areas, while infrastructure an …
  • Abengoa SA (ABG):企業の財務・戦略的SWOT分析
    Abengoa SA (ABG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • The Tokyo Star Bank Ltd:企業の戦略・SWOT・財務情報
    The Tokyo Star Bank Ltd - Strategy, SWOT and Corporate Finance Report Summary The Tokyo Star Bank Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Kudelski SA (KUD):企業の財務・戦略的SWOT分析
    Kudelski SA (KUD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Tandem Diabetes Care Inc (TNDM):企業の財務・戦略的SWOT分析
    Summary Tandem Diabetes Care Inc (Tandem) is a medical device manufacturing company that designs and develops diabetic care products. The company's product portfolio includes t:slim X2 insulin pump, basal-IQ technology, software and applications, infusion sets and other pump accessories. It also pro …
  • Andrade Gutierrez SA:企業の戦略的SWOT分析
    Andrade Gutierrez SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Einstein Noah Restaurant Group, Inc. (Foodservice):戦略・SWOT・企業財務分析
    Einstein Noah Restaurant Group, Inc. (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary Einstein Noah Restaurant Group, Inc. (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's struct …
  • Nutra Pharma Corp (NPHC):製薬・医療:M&Aディール及び事業提携情報
    Summary Nutra Pharma Corp (Nutra Pharma) acquires, licenses and commercializes pharmaceutical products, technologies, homeopathic drugs and ethical drugs for managing cancer, neurological disorders, autoimmune and infectious diseases, including human Immunodeficiency virus (HIV), multiple sclerosis …
  • Ohr Pharmaceutical Inc (OHRP):企業の財務・戦略的SWOT分析
    Summary Ohr Pharmaceutical Inc (Ohr), formerly BBM Holdings Inc, is a pharmaceutical company that develops novel therapies for ophthalmic diseases. The company offers products such as squalamine lactate ophthalmic solution and SKS sustained release technology products. Its squalamine lactate ophthal …
  • VisionCare Inc-医療機器分野:企業M&A・提携分析
    Summary VisionCare Inc (VisionCare) is a medical device company that researches, develops, manufactures, and markets proprietary implantable ophthalmic devices and technologies for the treatment of retinal disorders. The company offers implantable miniature telescope, an implantable medical device t …
  • Experian PLC (EXPN):企業の財務・戦略的SWOT分析
    Experian PLC (EXPN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Bone Therapeutics SA (BOTHE):製薬・医療:M&Aディール及び事業提携情報
    Summary Bone Therapeutics SA (Bone Therapeutics) is a cell therapy company that develops autologous and allogeneic cell therapy products. The company offers pipeline products such as PREOB, an autologous osteoblastic cell therapy product used for the treatment of osteonecrosis and non-union fracture …
  • Wiener Osiguranje Vienna Insurance Group d.d.:企業の戦略的SWOT分析
    Wiener Osiguranje Vienna Insurance Group d.d. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors …
  • Companhia Energetica de Sao Paulo (CESP6):電力:M&Aディール及び事業提携情報
    Summary Companhia Energetica de Sao Paulo (CESP) is a state-owned integrated electric utility. It plans, constructs, and operates electric energy generation and commercialization systems. The company produces energy using hydro source. CESP owns power plants at Rio Paran, Rio Paraibuna, and Rio Jagu …
  • OraSure Technologies Inc (OSUR)-医療機器分野:企業M&A・提携分析
    Summary OraSure Technologies Inc (OraSure) is a manufacturer and distributor of oral fluid specimen collection devices, diagnostic products and other medical devices. Its product portfolio encompasses infectious disease tests for the detection of antibodies for the HIV and Hepatitis C virus; and ant …
  • Arkansas Children’s Hospital:企業の戦略的SWOT分析
    Arkansas Children's Hospital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • Amerinac Holding Corp.:企業の戦略・SWOT・財務情報
    Amerinac Holding Corp. - Strategy, SWOT and Corporate Finance Report Summary Amerinac Holding Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆